Analysts Estimate Report : What to Look Out for MEI Pharma Stock Forecast, Price & News (NASDAQ:MEIP)

0
162

Earnings results for MEI Pharma Stock Forecast, Price & News (NASDAQ:MEIP)

MEI Pharma, Inc. is estimated to report earnings on 08/26/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.13. The reported EPS for the same quarter last year was $-0.02.

Analyst Opinion on MEI Pharma Stock Forecast, Price & News (NASDAQ:MEIP)

4 Wall Street analysts have issued ratings and price targets for MEI Pharma in the last 12 months. Their average twelve-month price target is $11.00, predicting that the stock has a possible upside of 302.93%. The high price target for MEIP is $13.00 and the low price target for MEIP is $9.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”

MEI Pharma has received a consensus rating of Buy. The company’s average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $11.00, MEI Pharma has a forecasted upside of 302.9% from its current price of $2.73. MEI Pharma has only been the subject of 3 research reports in the past 90 days.

Dividend Strength: MEI Pharma Stock Forecast, Price & News (NASDAQ:MEIP)

MEI Pharma does not currently pay a dividend. MEI Pharma does not have a long track record of dividend growth.

Insiders buying/selling: MEI Pharma Stock Forecast, Price & News (NASDAQ:MEIP)

In the past three months, MEI Pharma insiders have not sold or bought any company stock. Only 4.77% of the stock of MEI Pharma is held by insiders. 66.83% of the stock of MEI Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of MEI Pharma Stock Forecast, Price & News (NASDAQ:MEIP

Earnings for MEI Pharma are expected to decrease in the coming year, from ($0.06) to ($0.39) per share. The P/E ratio of MEI Pharma is -9.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of MEI Pharma is -9.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. MEI Pharma has a P/B Ratio of 4.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here